AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring

Investing.com Gold reports: AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring. Full body text was unavailable at ingest time, so this brief is based on headline context.